Ascentage Pharma Group International reported asset growth of 13.01% for the quarter ended Jun 2026. These growth metrics cover 3 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2024 | Dec2025 | Jun2026 |
|---|---|---|---|
| Growth Ratios | |||
| Assets Growth (1y) | 4.94% | 53.34% | 13.01% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | 15.57% | 98.35% | 20.46% |
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | -0.85% | -9.73% |